[144] Atomera Incorporated SEC Filing

Rhea-AI Filing Summary

Atomera Incorporated (ATOM) Form 144 notifies the SEC of a proposed sale of 9,314 common shares by a named holder through Morgan Stanley Smith Barney on 09/02/2025 on NASDAQ, with an aggregate market value of $29,437.09. The shares were acquired by vesting of restricted stock from the issuer on 09/01/2025 and were granted under the issuer's equity compensation plan. The filing also discloses prior sales by the same person within the past three months: 9,153 shares sold on 06/02/2025 for $54,938.07 and 128,002 shares sold on 06/12/2025 for $760,394.85. The filer certifies no undisclosed material adverse information and includes customary Rule 144 and Rule 10b5-1 representations.

Positive

• Transparent disclosure of the proposed sale and prior sales, meeting Rule 144 notification requirements
• Securities originated from issuer equity compensation (vesting of restricted stock), not an external purchase

Negative

• Substantial prior sale of 128,002 shares on 06/12/2025, which may indicate significant insider liquidity in the period
• Filing lacks details on the filer’s ownership percentage and whether a 10b5-1 trading plan is in effect (fields not populated)

Insights

Securities Analyst

TL;DR: Insider plans to sell recently vested equity (9,314 shares) via a broker; prior large sales occurred in June.

The filing documents a routine Rule 144 notice for an insider sale of 9,314 common shares arising from restricted stock vesting on 09/01/2025. Execution is slated for 09/02/2025 on NASDAQ through Morgan Stanley Smith Barney. Material prior dispositions by the same person are disclosed: 9,153 shares on 06/02/2025 and 128,002 shares on 06/12/2025, with aggregate gross proceeds of $815,332.92. From a compliance perspective the filing meets Rule 144 notification requirements and includes the standard representation about lack of undisclosed material information. Absent additional context about the filer’s ownership stake or company fundamentals, this notice alone is a routine insider liquidity event.

Corporate Governance Expert

TL;DR: The Form 144 is a standard disclosure of insider selling related to equity compensation vesting, complying with required certifications.

The transaction arises from restricted stock vesting under the issuer’s compensation plan, with sale arranged through a broker. The filer affirms compliance statements typical for Rule 144 and indicates no reliance on a 10b5-1 plan in the provided fields. The filing transparently lists prior sales in the past 90 days, which is relevant for aggregation rules and investor transparency. Without supplementary details (ownership %, filing signatory), governance implications are limited to routine disclosure practices rather than a material corporate development.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9314	29437.09	31482756	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2025	Vesting of Restricted Stock	Issuer			9314	09/01/2025	Granted as part of an issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Scott Bibaud 750 University Ave Suite 280 Los Gatos CA 95032	Common	06/02/2025	9153	54938.07
Scott Bibaud 750 University Ave Suite 280 Los Gatos CA 95032	Common	06/12/2025	128002	760394.85

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Atomera's (ATOM) Form 144 filed here notify?

The filing notifies a proposed sale of 9,314 common shares on 09/02/2025 via Morgan Stanley Smith Barney with an aggregate market value of $29,437.09.

How were the shares being sold by the filer acquired?

The 9,314 shares were acquired by vesting of restricted stock from the issuer on 09/01/2025, granted under the issuer’s equity compensation plan.

Did the filer sell other Atomera (ATOM) shares recently?

Yes. The filer sold 9,153 shares on 06/02/2025 for $54,938.07 and 128,002 shares on 06/12/2025 for $760,394.85.

On which exchange will the shares be sold?

The proposed sale is to be executed on NASDAQ.

Who is the broker handling the sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, New York, NY.